Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2014
05/06/2014US8715922 Virus causing respiratory tract illness in susceptible mammals
05/06/2014US8715695 Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits
05/06/2014US8715690 Circovirus sequences associated with piglet weight loss disease (PWD)
05/06/2014US8715688 Method for identification, isolation and production of antigens to a specific pathogen
05/06/2014US8715626 Cosmetic for hair containing co-modified organopolysiloxane
05/06/2014DE202005022124U1 Antimikrobielle Lösungen aus Taurinamid-Derivaten und biologisch verträglichen Salzen und Säuren unter Zugabe von geringen Heparinkonzentrationen Antimicrobial solutions taurinamide derivatives and biologically acceptable salts and acids with the addition of low concentrations of heparin
05/06/2014CA2798924C Improved methods for preparing squalene
05/06/2014CA2768290C R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for thepreparation thereof and pharmaceutical composition comprising the same for antimicrobial
05/06/2014CA2616210C Influenza vaccine compositions
05/06/2014CA2526150C Treatment of humans with colloidal silver composition
05/06/2014CA2511838C Uses of mammalian cytokine; related reagents
05/06/2014CA2475446C Viral variants with altered susceptibility to nucleoside analogs and uses thereof
05/06/2014CA2401327C Nucleic acid formulations comprising poly-amino acids for gene delivery and methods of use
05/01/2014WO2014066856A1 Inhalable influenza vaccine compositions and methods
05/01/2014WO2014066239A1 2',4'-bridged nucleosides for hcv infection
05/01/2014WO2014066162A1 Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection
05/01/2014WO2014065791A1 Hepatitis c virus inhibitors
05/01/2014WO2014065297A1 Silicon-containing compound aqueous solution and antibacterial/antiviral agent including said solution
05/01/2014WO2014065210A1 Vaccine for preventing porcine edema disease
05/01/2014WO2014064943A1 Antigenic peptide derived from dengue virus
05/01/2014WO2014064654A1 Derivatives of camptothecin, a method of producing them and their use
05/01/2014WO2014064652A2 Stable pharmaceutical composition of peginterferon alpha-2b
05/01/2014WO2014064409A1 Pharmaceutical antiretroviral composition
05/01/2014WO2014064397A1 Use of a flax extract, originating from the hydrolysis of flax proteins, as an active antimicrobial agent
05/01/2014WO2014063597A1 New cycloalkylamine compound useful in resisting mutant influenza virus
05/01/2014WO2014063477A1 Application of harmine derivatives in preparation of antimicrobial agents
05/01/2014WO2014063441A1 Triterpene derivative and its anti-influenza use
05/01/2014WO2014063289A1 Anti-cold medicament and preparation method
05/01/2014WO2014063288A1 Cold medicament and preparation method
05/01/2014WO2014063286A1 Medicament for treatment of common cold and preparation method
05/01/2014WO2014063282A1 Chinese medicine for treatment of common cold and preparation method
05/01/2014WO2014063253A1 Anti-campylobacter jejuni antibodies and uses therefor
05/01/2014WO2014033668A3 Combination of a macrocyclic protease inhibitor of hcv, a non-nucleoside hcv inhibitor and ritonavir
05/01/2014WO2014018295A4 Therapeutic anti-virus vlps
05/01/2014WO2013149121A8 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS
05/01/2014WO2013025834A9 Compositions and methods related to antibodies to staphylococcal protein a
05/01/2014WO2012145630A3 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
04/2014
04/30/2014EP2725100A1 Method for amplifying nk cells
04/30/2014EP2725029A1 New antibacterial compounds and biological applications thereof
04/30/2014EP2725015A1 Uracil or thymine derivative for treating hepatitis c
04/30/2014EP2724707A2 Hair care products with anti-dandruff ingredients and a cationic keratin hydrolysate
04/30/2014EP2723881A2 Novel crystalline cefoperazone intermediate
04/30/2014EP2723863A1 Hcv combination therapy
04/30/2014EP2723743A1 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
04/30/2014EP2723742A1 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
04/30/2014EP2723737A1 Bridged bicyclic compounds for the treatment of bacterial infections
04/30/2014EP2723452A2 Conjugate-based antifungal and antibacterial prodrugs
04/30/2014EP2723385A1 Film-forming composition, and use thereof for treating herpes
04/30/2014EP2723369A2 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
04/30/2014EP2723343A2 Process of forming crystals for use in a personal care composition
04/30/2014EP2723342A1 Use of 10h-benzo[g]pteridine-2,4-dione derivatives
04/30/2014EP2723337A1 Treatment of hepatitis c virus
04/30/2014EP2723334A2 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
04/30/2014EP2723332A1 Novel compounds as diacylglycerol acyltransferase inhibitors
04/30/2014EP2723331A2 Non-leaching antimicrobial wound dressing
04/30/2014EP2723326A1 Topical film-forming composition, and use thereof for treating mycoses
04/30/2014CN103764817A Recombinant swine influenza virus and uses thereof
04/30/2014CN103764654A Inhibitors of influenza viruses replication
04/30/2014CN103764647A Metalloenzyme inhibitor compounds
04/30/2014CN103764228A Leukotoxin E/D as a new anti-inflammatory agent and microbicide
04/30/2014CN103764171A Tyrosine ligation process
04/30/2014CN103764157A Influenza virus infection inhibitor
04/30/2014CN103764143A Lipoxygenase inhibitors
04/30/2014CN103764141A Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
04/30/2014CN103764140A Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
04/30/2014CN103764137A Eosinophil peroxidase compositions and methods of their use
04/30/2014CN103757054A Recombinant replication-deficient adenovirus vector equine influenza (EI) genetic engineering vaccine and application thereof
04/30/2014CN103757041A Method for preparing swine-original interferon-gamma 3 and application
04/30/2014CN103757032A Chimeric HCV (hepatitis C virus) vaccine taking influenza virus as carrier and preparation method thereof
04/30/2014CN103757001A Preparation of cell fine particle-siRNA (small interfering Ribose Nucleic Acid) compound and application of cell fine particle-siRNA compound to treatment of AIDS
04/30/2014CN103756977A gE- and gI-deleted porcine pseudorabies virus variant strain and use thereof
04/30/2014CN103756976A Diploid cell adaptive method of F genotype mumps viral strain MHM-19
04/30/2014CN103756974A Porcine epidemic diarrhea virus, and culture method and application thereof
04/30/2014CN103756942A Escherichia coli strain and dairy cow mastitis vaccine obtained by inactivating same
04/30/2014CN103756813A Aesthetic health care perfumed soap and preparation method thereof
04/30/2014CN103755840A Synanthrin derivative containing 1,2,3-triazole and preparation method thereof
04/30/2014CN103755810A Long-acting HIV-1 membrane fusion inhibitor
04/30/2014CN103755805A Human monoclonal antibody with HIV-1 Env specificity
04/30/2014CN103755795A Saddletail grouper antimicrobial peptide LEAP-2 gene, vector, recombinant strain and protein, and application thereof
04/30/2014CN103755789A Regulatory T cell epitopes, compositions and uses thereof
04/30/2014CN103755784A Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
04/30/2014CN103755730A Marbofloxacin-calcium chelate and synthetic method and application thereof
04/30/2014CN103755728A Cefazolin derivative and preparation method thereof as well as oral antibiotic preparation
04/30/2014CN103755724A Penicillin derivatives and applications thereof
04/30/2014CN103755714A Phthalocyanine-hydrotalcite complex and preparation method and application thereof
04/30/2014CN103755713A Octa-sulfonic phthalocyanine, and preparation method and application thereof
04/30/2014CN103755697A 3-[[2-(2-benzylamino) thiazole-5-yl]-methyl] quinolone-2(1H)-ketone as well as preparation and application thereof
04/30/2014CN103755560A 2-hydroxyl-4-n-propyl-1-tropone ester or salt and application thereof in preparing antibacterial agent for animals and growth promoter for feed
04/30/2014CN103755541A Chalcone derivative as well as preparation method and application thereof
04/30/2014CN103751807A Method for controlling CSBV (Chinese bee Sacbrood Virus) by utilizing RNA interference technology
04/30/2014CN103751796A Straight-chain polyethylene glycol-recombinant porcine interferon alpha conjugate, and preparing method and application thereof
04/30/2014CN103751790A Dermal film-forming liquid formulations for drug release to skin
04/30/2014CN103751779A Poloxamer gel adjuvant for O-typed foot and mouth disease polypeptides
04/30/2014CN103751776A Oxidized astragalus mixture and application thereof
04/30/2014CN103751774A Recombinant cell line for stably expressing classical swine fever virus E2 protein, and applications of the same in preparation of subunit vaccines and diagnosis reagents of classical swine fever
04/30/2014CN103751773A Recombinant BHK cell line for stably expressing classical swine fever virus E0-E1-E2 protein, and applications of the same in preparation of vaccines and diagnosis reagents of classical swine fever
04/30/2014CN103751772A Method for preparing genotype F mumps attenuated live vaccine
04/30/2014CN103751739A Traditional Chinese medicine composition for treating chronic gastritis, application of composition in preparation of medicine for treating chronic gastritis, and preparation method of composition
04/30/2014CN103751725A Anti-inflammatory medicine with effects of sterilizing, removing acnes and whitening skin
04/30/2014CN103751706A Anti-cancer traditional Chinese medicine composition and application thereof
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 1798